RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

CompletedOBSERVATIONAL
Enrollment

719

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Acute Coronary SyndromeMyocardial InfarctionHeart FailureCongestive Heart Failure
Interventions
DEVICE

RAMP 200

The RAMP® Reader is a general use fluorometer that analyzes results produced by immunoassays that use a fluorophore having an excitation wavelength at 560 nm and an emission wavelength of 610 nm. The RAMP® 200 is Response Biomedical's second generation reader. The RAMP® 200 is designed to process more tests with a smaller footprint.

DEVICE

RAMP Reader

The RAMP® Reader is a general use fluorometer that analyzes results produced by immunoassays that use a fluorophore having an excitation wavelength at 560 nm and an emission wavelength of 610 nm. The RAMP® Reader is Response Biomedical's first generation reader instrument. Designed for use at near-patient/bedside or locations such as: laboratories, hospitals, on-site Emergency Response and Emergency Rooms.

Trial Locations (3)

21201

University of Maryland Medical Center, Baltimore

55404

Minneapolis Medical Research Foundation, Minneapolis

94110

San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

Response Biomedical Corp.

INDUSTRY

NCT02191735 - RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care | Biotech Hunter | Biotech Hunter